Bristol-Myers Squibb Company (BMY) Stock Ratings

View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:


50% of 2 ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks

Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
Netteligent Netteligent 07/14/2016 1 month $76.77 $75.56 -1.58% 1 Active
Comments: Deadman walking. Speculation. High Risk
RonaldH RonaldH 07/01/2016 3 months $73.72 $75.56 +2.5% 2 Active
prometheusX prometheusX 08/05/2015 1 month $65.41 $57.33 -12.35% -12 Ended
LeonMcClendon LeonMcClendon 10/07/2014 3 months $49.77 $59.51 +19.57% 19 Ended
Comments: Upcoming product launch will be successful
Dr.Timothy W Price Dr.Timothy W Price 05/18/2014 3 months $48.78 $49.66 +1.8% 1 Ended
Comments: I own stocks in this and make money too !
GiorgiKakabadze GiorgiKakabadze 03/12/2013 3 months $38.12 $47.45 +24.49% 24 Ended
4William 4William 12/01/2012 1 week $32.63 $32.55 -0.25% 1 Ended
Bobby_41 Bobby_41 04/16/2012 3 months $32.54 $35.37 +8.7% 8 Ended
Comments: Industry sector growing or poised for growth
magicdad magicdad 02/22/2012 3 months $32.23 $32.71 +1.49% 1 Ended
Comments: Industry sector growing or poised for growth
Izabelka Izabelka 01/16/2011 1 month $25.84 $36.15 +39.9% 39 Ended
Comments: Good company with great dividend
rtcoliveira rtcoliveira 07/27/2010 3 months N/A Ended
Comments: best pipeline in the pharmaceutical industry
Xande Xande 07/27/2010 3 months N/A Ended
Comments: This is a solid company with strong management. Has very solid financial situation, and is on a market place that has little impact from crisis. Its patent losses are going to be compensated by NEW.
FANman FANman 07/10/2010 3 months N/A Ended
Comments: ,

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.